Trump Nominates New Health Leaders, Aims to Restore FDA Trust
On Friday, President-elect Donald J. Trump revealed his intention to nominate Dr. Martin A. Makary, a surgeon from Johns Hopkins University, as the new commissioner of the Food and Drug Administration (FDA). This announcement came through a social media post where Mr. Trump criticized the FDA, stating that it has "lost the trust of Americans" and fallen short of its role as a key health regulator.
Dr. Makary will collaborate with Robert F. Kennedy Jr., whom Trump has selected to serve as health secretary. Together, they aim to thoroughly investigate the harmful chemicals affecting the nation’s food and drug supplies. Trump expressed confidence in Dr. Makary’s commitment to improving healthcare quality while ensuring affordability, suggesting that his leadership would elevate the FDA to a "gold standard" in scientific research and reduce bureaucratic hurdles for better access to medical treatments.
In addition to Dr. Makary’s nomination, Trump announced two other significant health appointments. Dr. Dave Weldon, a physician and former congressman from Florida, has been picked to lead the Centers for Disease Control and Prevention (CDC). Dr. Weldon has previously supported controversial claims regarding vaccines and their safety.
Furthermore, Trump proposed Dr. Janette Nesheiwat, a physician and contributor on Fox News, to take on the role of surgeon general. Dr. Nesheiwat has experience with patient care following Hurricane Katrina and has been actively involved in addressing health challenges during the COVID-19 pandemic in New York City.
These appointments are part of Trump’s broader strategy to reshape the nation’s health policies and restore public faith in its healthcare institutions.
